Company: ADPT
Filing Date: 2025-06-12
Form Type: 8-K
Source: 0001193125-25-140017
Chunk: 0

Company: Adaptive Biotechnologies Corp
Filing Date: 2025-06-12
Form: 8-K
Item: Item 5.07
Chunk 0
---
Item 5.07 Submission of Matters to a Vote of Security Holders.

On June 10, 2025, Adaptive Biotechnologies Corporation (the “ Company”) held its annual meeting of shareholders (the “ Annual Meeting”) pursuant to notice duly given. Three proposals were presented for voting: Proposal 1: election of the Class III director to the Board of Directors (Chad Robins); Proposal 2: an advisory request concerning compensation for the Company’s 2024 named executive officers; and, Proposal 3: ratification of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2025. Each of the proposals was described in detail in the Company’s definitive proxy statement on Schedule 14A filed with the U. S. Securities and Exchange Commission on April 29, 2025. A quorum of the shareholders voted by the conclusion of the Annual Meeting. The final results of the voting are set forth below.